GENE THERAPY FOR
CANCER PATIENTS
How genetic modification technologies are being used to fight cancer โ from viral vectors and CRISPR editing to oncolytic viruses.
What Is Gene Therapy for Cancer?
Gene therapy modifies genetic material within cells to treat or prevent disease. In cancer, this means introducing genes that kill tumor cells, repairing mutated tumor-suppressor genes, or engineering immune cells to better recognize cancer.
โGene therapy attacks cancer at its root cause โ the corrupted genetic code driving tumor growth.โ
Types of Gene Therapy for Cancer
Viral Vector Gene Delivery
Modified viruses (adenovirus, lentivirus, AAV) deliver therapeutic genes directly into cancer cells or immune cells.
CRISPR Gene Editing
Precise DNA editing to knock out oncogenes, repair tumor suppressors, or enhance immune cell function.
Oncolytic Virus Therapy
Engineered viruses that selectively infect and lyse cancer cells while sparing normal tissue. T-VEC (Imlygic) is FDA-approved.
Gene Silencing (RNAi/ASO)
RNA interference or antisense oligonucleotides silence cancer-promoting genes at the mRNA level.
Approved & Late-Stage Gene Therapies for Cancer
| Product | Type | Cancer | Status |
|---|---|---|---|
| T-VEC (Imlygic) | Oncolytic virus | Advanced melanoma | FDA approved |
| Gendicine | p53 adenovirus | Head & neck squamous cell | Approved in China |
| CAR-T products | Lentiviral gene transfer | Blood cancers | FDA approved (6 products) |
| CRISPR-edited TILs | Gene editing + cell therapy | Solid tumors | Phase 1/2 trials |
Gene Therapy: Benefits vs Limitations
Benefits
- Targets root genetic causesAddresses the mutations driving cancer.
- Potential for lasting effectOne-time genetic modification can provide durable results.
- Combinable with other therapiesGene-modified cells can enhance immunotherapy.
Limitations
- Delivery challengesGetting genes into the right cells remains difficult.
- Safety concernsInsertional mutagenesis and off-target editing risks.
- High cost and complexityPersonalized manufacturing is expensive and slow.
Frequently Asked Questions
About Gene Therapy for Cancer
How CancerFax Helps
CancerFax is a specialist cancer access and patient-navigation platform. We help patients and families understand their options, organise medical records, coordinate hospital communication, and support cross-border treatment planning where appropriate.
We help collect and organise reports, scans, pathology, biomarker results, and treatment history for structured case review.
We communicate with hospitals or trial teams to assess whether a case may be suitable for further screening.
We support appointment coordination, document submission, translation, and direct communication with international departments.
For international patients, we help with practical coordination โ travel planning, hospital admission guidance, and local support.
If this option is not suitable, we help explore other relevant treatments, clinical trials, or advanced care pathways.
From inquiry through to follow-up, our coordinators provide a single point of contact for the family.
CancerFax does not guarantee treatment access, eligibility, or clinical outcome. Our role is to help patients access accurate information, structured review, and appropriate specialist pathways.
Exploring Gene Therapy Options for Cancer?
Upload your reports and our team will evaluate gene therapy options including CAR-T, oncolytic virus, and clinical trials.
This content is for informational purposes only and does not constitute medical advice. Always consult a qualified oncologist before making treatment decisions.